Patients with relapsed or refractory CD19-positive B-cell acute lymphoblastic leukemia ... it from the very different disease of chronic lymphocytic leukemia, which has a potential time course ...
AbbVie announced groundbreaking results today from its latest Emotional Impact Report (EIR), a patient survey that provides an understanding of the ...
BeiGene, Ltd. , a global oncology company that intends to change its name to BeOne Medicines Ltd., today announced its new partnership with CLL Society, the world's leading authority for chronic ...
Results from a clinical trial ... Changes in Blood Cell Production Over the Lifetime Could Impact Leukemia Outcomes Dec. 5, 2024 — The first comprehensive map of the dramatic changes that take ...